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Meeting Report
The Impact of Hypoxia on Cells, Mice, and Men
Max Gassmann, Omolara O. Ogunshola, and Martha Tissot van Patot
This is a report of the HypoxiaNet meeting that tookplace at Monte Verita` in Ascona, Switzerland, October 9–
14, 2011. It was the third in a series of meetings held at Monte
Verita` designed to bring together biomedical scientists and
clinician researchers who study the role of hypoxia in diverse
fields. Initially, investigations into the role of hypoxia in the
etiology of disease were limited to the pulmonary field par-
ticularly in relation to the effects of rapid ascent to and resi-
dence at high altitude. Over the past 20 years, it has become
increasingly apparent that hypoxia plays a significant role in
an enormous variety of diseases, from pregnancy disorders to
formation of tumors. This meeting series was the first dedi-
cated to bringing together basic research scientists, physi-
ologists and clinicians from widely differing backgrounds to
compare and contrast the role of hypoxia in specific cellular
and animal models as well as different human disorders and
diseases.
These close-knit meetings are designed such that the
maximum of 100 attendees, including speakers, attend a sin-
gle series of lectures throughout the day. All participants stay
at the beautiful and historic Monte Verita` Hotel and Con-
ference Center, taking meals together at large community
tables. This arrangement provides extensive opportunities for
discussion and developing unique collaborations. The at-
tendees embraced the spirit of the meeting with molecular
biologists attending presentations on high altitude-induced
disease and clinical oncologists attending sessions on the role
of mitochondria in hypoxic cells.
The current meeting was divided into seminars focusing on
areas such as the roles of specific molecular pathways in
hypoxia (HIFs, PHDs, and erythropoietin), physiological
pathways (mitochondrial respiration, ventilation), specific
organ responses to hypoxia (eye, placenta, gut) and clinical
repercussions (exercise, high altitude cerebral and pulmonary
edemas, adaptation). Despite speakers from a highly varied
number of scientific fields, it became clear that there was a
thread of important commonalities throughout the research
presentations, tying data together into a global view of hyp-
oxic response.
As such, the keynote lecture by Dr. William G. Kaelin,
M.D., describing new cancer therapies developed from recent
understanding of the molecular pathways in the mammalian
oxygen sensing pathways, focusing primarily on HIF prolyl
hydroxylases (PHDs), proved prophetic and provided a great
foundation for the start of the conference. PHD involvement
was demonstrated throughout the meeting in a wide-ranging
list of diseases including, cardiomyopathy (Katschinski, DM),
cardiac ischemic reperfusion injury (Koivunen, P), inflam-
matory bowel disease (Taylor, C), and Tibetan adaptation to
high altitude residence (Prchal, J).
Mitochondria activity was another commonality among
hypoxia research presentations including generation of re-
active oxygen species (Schumaker, P), hydrogen sulfide
production/carotid body sensitivity (Kemp, P), placental
development at high altitude (Tissot van Patot, M), adapta-
tion to high altitude ascent (Gelfi, C), exercise (Gnaiger,E),
body weight control (Aragone´s, J), ischemia-reperfusion lung
injury (Weissmann, N), breast cancer (Gorr, T), and ischemic
cardioprotection (Koivunen, P). Mitochondrial response to
hypoxia seems to be common denominator in numerous
hypoxia-mediated conditions potentially providing another
strong target for developing therapeutic interventions.
The more recently defined role of epigenetics in response to
hypoxia was prominently discussed in a variety of conditions
as well. Data were presented implicating hypoxia in altering
epigenetics via chromatin remodeling (Poellinger, L), miR-
NAs (Gay, S), and DNA methylation (Sartori, C) in cancer,
rheumatoid arthritis, and pulmonary hypertension, respec-
tively. The potential role for the amazing capacity of epige-
netics to be altered in a single generation was then further
discussed in presentations focusing on adaptations in second
generations at altitude, adaptation of llamas (Llanos, A), and
population adaptation in Tibetans and Andeans (Prchal, J).
Subsequently, evidence of hypoxia-induced rough endoplas-
mic reticular stress, modifications in protein synthesis and/or
effects on cellular proliferation and migration was presented
in association with metastasis ( Johnson, R), retinal develop-
ment (Grimm C) and disease (Bo¨sch, M), as well as placental
adaptation to high altitude (Burton, G). Interestingly, expo-
sure of healthy volunteers to high altitude (Capanna Mar-
gherita) was shown to cause ulceration in the stomach (Lutz,
T; Goetze, O). Finally, Jerry Dempsey reviewed the causes and
consequences of hypoxic ventilatory acclimatization.
Recent evidence that erythropoietin (Epo) has multiple
non-erythroid functions was expanded by data implicating
Epo in exercise performance by hematological and non-
hematological functions (Gassmann, M), improved cognition
(Ehrenreich, H) and mood disorders (Miskowiak, K), retinal
function (Rex, T), neonatal ventilation (Soliz, J), and protec-
tion from ventilator-induced lung injury (Swenson, E). An
excellent debate of the mode of action of Epo protection and
physiological effects was also initiated in these sessions.
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Other similarities between hypoxic research areas include
iron homeostasis implicated in kidney fibrosis (Haase, V.) and
skeletal muscle response (Gelfi, C), nitric oxide implicated in
ischemic cardioprotection (Koivunen, P), differential activa-
tion of HIF-1 and HIF-2 ( Johnson, R), and control of S-
glutathionylation (Bogdanova, A).
An excellent set of sessions on response to high altitude
provided a valuable context in which to view the variety
of hypoxia-induced pathways coming together for a global
physiologic/pathophysiologic response. There were lively
debates about the role of Epo in exercise, the limitations of
exercise at altitude and the role of doping in climbers.
The questions surrounding the doping issue included: is
prevention or treatment of altitude illness doping and
what constitutes doping in elite climbers? (chair: Oelz, O).
There was also an interesting discussion session in
which a consensus on the prevention and treatment of
high altitude pulmonary edema (HAPE) was sought
(chair: Maggiorini, M). Data on exercise and pulmonary
capacity, pulmonary disease and altitude ascent, HAPE
susceptibility and a variety of presentations on treatments
including ascent rate recommendations, oxygen, acetazol-
amide, phosphodiesterase 5 inhibitors, steroids and beta-3
agonist formed the context in which a consensus on HAPE
was based.
Because of the meeting environment, the excellent science,
the novel mixture of scientific fields all surrounding hypoxia,
the organization of the workshops, and the excellent discussions
during the presentations, the meeting was an unparalleled
success. The meeting successfully achieved the projected goals
of bringing together scientists to discuss the state of the art in our
understanding of the effects of hypoxia on the body, from de-
velopment to aging as well as during pathophysiology pro-
cesses, and developing new directions for future exploration.
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